It’s big news for millions of Americans with Type 1 diabetes.
Exercise is known to improve the ability of tissues to respond to insulin and reduce the risk for developing type 2 diabetes, but the mechanisms that cause those health benefits are not yet clear.
Metabolic Solutions Development Co. LLC has presented new data showing that an investigational drug being studied to treat diabetes, MSDC-0160, had a protective effect on nerve cells in the brain that control movement, balance and walking. These results in laboratory and animal models of Parkinson’s disease suggest MSDC-0160 may have the potential to modify the course of Parkinson’s disease.
With the assistance of the Southeast Michigan Beacon Community, the Emergency Department at DMC Detroit Receiving Hospital has developed an innovative program that is identifying previously unknown diabetics and pre-diabetics who receive care at their facility, and reducing their likelihood of using the emergency department at DMC Detroit Receiving within six months by 57 percent.
Perrigo Co. (Nasdaq: PRGO) announced that it has received tentative approval from the United States Food & Drug Administration for its abbreviated new drug application for repaglinide tablets, the generic equivalent to Prandin Tablets.
A new British study suggests just one sugar-sweetened beverage a day, can raise the risk of developing type two diabetes by as much to 22 percent.
A device used by diabetics has been recalled.
Diabetes patients who took a heart drug canadidate from Esperion Therapeutics, ETC 1002, found their so-called bad choleseterol, LDL-C, fall up to 43 percent, the company reported Monday.
A local organization is looking to help 100 low-income metro Detroiters with Type Two Diabetes
With the holidays here, it’s a perfect time to take stock of how we’re doing – health wise.